EE03091B1 - Kompositsioon vereplasma stabiliseerimiseks pastöriseerimisel, meetod vereplasma pastöriseerimiseks ning sellel meetodil saadud produktid teraapiliseks kasutamiseks - Google Patents

Kompositsioon vereplasma stabiliseerimiseks pastöriseerimisel, meetod vereplasma pastöriseerimiseks ning sellel meetodil saadud produktid teraapiliseks kasutamiseks

Info

Publication number
EE03091B1
EE03091B1 EE9400005A EE9400005A EE03091B1 EE 03091 B1 EE03091 B1 EE 03091B1 EE 9400005 A EE9400005 A EE 9400005A EE 9400005 A EE9400005 A EE 9400005A EE 03091 B1 EE03091 B1 EE 03091B1
Authority
EE
Estonia
Prior art keywords
plasma
composition
therapeutic use
pasteurizing
pasteurization
Prior art date
Application number
EE9400005A
Other languages
English (en)
Estonian (et)
Inventor
Burnouf Miryana
Original Assignee
Association pour l'Essor de la Transfusion Sanguine dans la R�gion du Nord
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Association pour l'Essor de la Transfusion Sanguine dans la R�gion du Nord filed Critical Association pour l'Essor de la Transfusion Sanguine dans la R�gion du Nord
Publication of EE03091B1 publication Critical patent/EE03091B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
EE9400005A 1992-02-13 1994-05-23 Kompositsioon vereplasma stabiliseerimiseks pastöriseerimisel, meetod vereplasma pastöriseerimiseks ning sellel meetodil saadud produktid teraapiliseks kasutamiseks EE03091B1 (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9201604A FR2687317B1 (fr) 1992-02-13 1992-02-13 Composition pour stabiliser le plasma sanguin en cour de pasteurisation et solution plasmatique pasteurisee a usage therapeutique.

Publications (1)

Publication Number Publication Date
EE03091B1 true EE03091B1 (et) 1998-06-15

Family

ID=9426597

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400005A EE03091B1 (et) 1992-02-13 1994-05-23 Kompositsioon vereplasma stabiliseerimiseks pastöriseerimisel, meetod vereplasma pastöriseerimiseks ning sellel meetodil saadud produktid teraapiliseks kasutamiseks

Country Status (20)

Country Link
EP (1) EP0556096B1 (xx)
JP (2) JP4010573B2 (xx)
AT (1) ATE171074T1 (xx)
BR (1) BR9300524A (xx)
CA (1) CA2089446C (xx)
CZ (1) CZ285573B6 (xx)
DE (1) DE69321007T2 (xx)
DK (1) DK0556096T3 (xx)
EE (1) EE03091B1 (xx)
ES (1) ES2121065T3 (xx)
FI (1) FI103380B (xx)
FR (1) FR2687317B1 (xx)
HU (1) HU210026B (xx)
LT (1) LT3226B (xx)
LV (1) LV10195B (xx)
NO (1) NO306532B1 (xx)
PL (1) PL174098B1 (xx)
RU (1) RU2112522C1 (xx)
SK (1) SK280665B6 (xx)
UA (1) UA27102C2 (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501189D0 (sv) * 1995-03-31 1995-03-31 Pharmacia Ab Protein formulation
US5616159A (en) * 1995-04-14 1997-04-01 Corning Incorporated Method of forming high purity fused silica having high resistance to optical damage
US6619073B2 (en) 1996-03-05 2003-09-16 Corning Incorporated Method of increasing the initial transmittance of optical glass
US5879875A (en) * 1996-06-14 1999-03-09 Biostore New Zealand Compositions and methods for the preservation of living tissues
AU725247B2 (en) * 1996-06-14 2000-10-12 Biostore New Zealand Limited Compositions and methods for the preservation of living tissues
US6361933B1 (en) 1996-06-14 2002-03-26 Biostore New Zealand Limited Solutions for the preservation of tissues
US6114107A (en) * 1996-06-14 2000-09-05 Biostore New Zealand Limited Composition comprising raffinose, TMAO, sodium citrate and methods for the preservation of living tissues
US6037116A (en) * 1996-06-14 2000-03-14 Biostore New Zealand, Ltd. Compositions comprising betaine, sodium citrate and sodium chloride and methods for the preservation of biological materials
US5962213A (en) * 1996-06-14 1999-10-05 Biostore New Zealand Limited Compositions and methods for the preservation of living tissues
US5827640A (en) * 1996-06-14 1998-10-27 Biostore New Zealand Limited Methods for the preservation of cells and tissues using trimethylamine oxide or betaine with raffinose or trehalose
US6915665B2 (en) 2000-10-31 2005-07-12 Corning Incorporated Method of inducing transmission in optical lithography preforms
US20060019234A1 (en) * 2004-07-22 2006-01-26 Shanbrom Technologies, Llc Modern blood banking employing improved cell preservation composition
ES2264403B1 (es) * 2006-06-22 2007-11-01 Grifols S.A. Medio de suspension de hematies.
DE102011056142A1 (de) * 2011-12-07 2013-06-13 Manfred Rüdinger Metabolisierbare Salze und deren Verwendung in Diagnostik und Therapie
RU2639446C1 (ru) * 2016-11-23 2017-12-21 Федеральное государственное бюджетное образовательное учреждение высшего образования "Ярославский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ хранения плазмы крови, содержащей лекарственные вещества с нестабильными фенольными гидроксилами

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3045153A1 (de) * 1980-11-29 1982-07-08 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ix und x
DE3230849A1 (de) * 1982-08-19 1984-02-23 Behringwerke Ag, 3550 Marburg Pasteurisiertes human-fibrinogen (hf) und verfahren zu dessen herstellung
DE3237512A1 (de) * 1982-10-09 1984-04-12 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von antihaemophilem kryopraezipitat (ahk) und danach hergestelltes antihaemophiles kryopraezipitat
US4470968A (en) * 1983-01-13 1984-09-11 Miles Laboratories, Inc. Pasteurized therapeutically active blood coagulation factor concentrates
JPS59134730A (ja) * 1983-01-20 1984-08-02 Green Cross Corp:The 血液凝固第８因子の加熱処理法
DE3330770A1 (de) * 1983-08-26 1985-03-14 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von humanplasma
FR2650508A1 (fr) * 1989-08-01 1991-02-08 Fondation Nale Transfusion San Colle pasteurisee pour reunir des tissus humain ou animal
FR2664165B1 (fr) 1990-07-03 1992-10-16 Lille Transfusion Sanguine Composition pour stabiliser le plasma sanguin en cours de pasteurisation.

Also Published As

Publication number Publication date
UA27102C2 (uk) 2000-02-28
CZ285573B6 (cs) 1999-09-15
EP0556096B1 (fr) 1998-09-16
DK0556096T3 (da) 1999-06-14
LT3226B (en) 1995-04-25
FR2687317A1 (fr) 1993-08-20
DE69321007D1 (de) 1998-10-22
RU2112522C1 (ru) 1998-06-10
FI103380B1 (fi) 1999-06-30
JP4472672B2 (ja) 2010-06-02
JP2006306892A (ja) 2006-11-09
CA2089446C (fr) 2006-04-18
HU210026B (en) 1995-01-30
NO930473D0 (no) 1993-02-11
LV10195B (en) 1995-04-20
CA2089446A1 (fr) 1993-08-14
FI930630A (fi) 1993-08-14
LTIP338A (en) 1994-08-25
BR9300524A (pt) 1993-09-28
ATE171074T1 (de) 1998-10-15
CZ16193A3 (en) 1993-12-15
EP0556096A1 (fr) 1993-08-18
FR2687317B1 (fr) 1995-06-23
SK8293A3 (en) 1993-10-06
LV10195A (lv) 1994-10-20
NO306532B1 (no) 1999-11-22
JP4010573B2 (ja) 2007-11-21
HU9300377D0 (en) 1993-04-28
DE69321007T2 (de) 1999-04-01
FI930630A0 (fi) 1993-02-12
ES2121065T3 (es) 1998-11-16
NO930473L (no) 1993-08-16
PL174098B1 (pl) 1998-06-30
HUT63768A (en) 1993-10-28
JPH0624997A (ja) 1994-02-01
PL297699A1 (en) 1994-01-10
SK280665B6 (sk) 2000-05-16
FI103380B (fi) 1999-06-30

Similar Documents

Publication Publication Date Title
EE03091B1 (et) Kompositsioon vereplasma stabiliseerimiseks pastöriseerimisel, meetod vereplasma pastöriseerimiseks ning sellel meetodil saadud produktid teraapiliseks kasutamiseks
ES2016336B3 (es) Bebidas de jugos de frutas y concentrados de jugos suplementados nutricionalmente con calcio.
RU93004727A (ru) Состав для стабилизации плазмы крови, способ пастеризации плазмы и использование стабилизированной плазмы в терапии
GR3024459T3 (en) Refrigerated, pasteurized and spreadable meat or fish mousse and process of manufacturing the same
FR2664165B1 (fr) Composition pour stabiliser le plasma sanguin en cours de pasteurisation.
ATE129128T1 (de) Emulgierte, den geschmack modifizierende zusammensetzung.

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

GB1A Change in the ownership or in the address of the owner
KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20110523